Innovating Works

COVALAB

Desconocido
CHIRON: The role of the non-canonical death receptor signalling in cancer and immune cells COVALAB SAS participó en un HORIZON EUROPE: HORIZON-MSCA-2022-SE-01 Immune surveillance refers to the ability of the immune system to efficiently induce cell death (apoptosis) in aberrant cells during the ear...
2023-06-26 - 2027-09-30 | Financiado
PASSPORK: A Multi Pathogen Pre Screening Tool for Safer Pork Products COVALAB SAS participó en un FP7: Within the European meat sector the pork industry is crucial in terms of consumption and commercial importance; pork is the most produced an...
Financiado
TRANSPATH: Transglutaminase in disease a novel therapeutic target? COVALAB SAS participó en un FP7: TRANSPATH is a multisectorial Network designed to facilitate the exchange of knowledge and technology between 7 leading European research te...
Financiado
TRANSCOM: The Commercialisation of Transglutaminase. COVALAB SAS participó en un FP7: The TRANSCOM project is designed to facilitate the exchange of knowledge and technology between 3 leading European research teams and 4 SMEs...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.